4//SEC Filing
IMMUNOGEN INC 4
Accession 0001179110-14-003416
CIK 0000855654operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 2:20 PM ET
Size
8.4 KB
Accession
0001179110-14-003416
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Morris Charles Q
Executive VP & CDO
Transactions
- Sale
Common Stock
2014-02-20$17.10/sh−13,672$233,737→ 37,500 total - Exercise/Conversion
Stock Option (right to buy)
2014-02-20$11.93/sh−13,672$163,107→ 179,190 totalExercise: $11.93From: 2013-11-26Exp: 2022-11-26→ Common Stock (13,672 underlying) - Exercise/Conversion
Common Stock
2014-02-20$11.93/sh+13,672$163,107→ 51,172 total
Footnotes (3)
- [F1]Weighted average price of shares sold.
- [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on August 29, 2013.
- [F3]Exercisable as to 50,000 shares commencing on November 26, 2013, 50,000 shares commencing on November 26, 2014, 50,000 shares commencing on November 26, 2015, and 50,000 shares commencing on November 26, 2016.
Documents
Issuer
IMMUNOGEN INC
CIK 0000855654
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000855654
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 2:20 PM ET
- Size
- 8.4 KB